|
Home |
Activism
Alerts |
Contact Government
Officials |
Contact Media
Outlets |
|
Patient
Resources |
A Guide to CIND
|
Glossary
|
News/Announcements
|
| For More
Information |
| WEST POINT, PA. -- October 25, 1999 -- Results of a
new study published this month in the journal Gastroenterology show
that osteoarthritis patients taking Vioxx® (rofecoxib) developed
significantly fewer endoscopic ulcers than patients taking ibuprofen, a
commonly used arthritis medicine.
Read the complete article at: http://www.pslgroup.com/dg/13e42e.htm |
|
Home
| Activism Alerts
| Contact
Government Officials | Contact
Media Outlets |
| Patient
Resources | A Guide
to CIND | Glossary
|
News/Announcements
|
| For More Information |
© Copyright
1999-2001 The Chronic Syndrome Support Association, Inc.
All Rights Reserved
Contact
Webmaster
Most recent revision
Saturday, November 10, 2001
Design & development by:
